Oestrogen receptors and cardiovascular disease

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 6-7, 1996, Pages 537-548

  Baysal, Kemal ^a   Losordo, Douglas W ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

Author keywords

atherosclerosis; oestrogen receptor

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; FULVESTRANT; TAMOXIFEN;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CELL PROLIFERATION; CORONARY ARTERY ATHEROSCLEROSIS; GENE CONTROL; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; IMMUNOHISTOCHEMISTRY; PREMENOPAUSE; VASCULAR SMOOTH MUSCLE;

EID: 0029885523     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb02775.x     Document Type: Article

References (82)

1. Levy H, Boas EP. Coronary artery disease in women. JAMA 1936; 107: 97.
2. Glendy RE, Levine SA, White PD. Coronary disease in youth: Comparison of 100 patients under 40 with 300 persons past 80. JAMA 1937; 109: 1775-8.
3. Master AM, Dack S, Jaffe HL. Age, sex and hypertension in myocardial infarction due to coronary occlusion. Arch. Intern. Med. 1939; 64: 767.
4. Clawson BJ. The incidence of types of heart disease among 30, 265 autopsies, with special reference to age and sex. Am. Heart J. 1941; 22: 607.
5. Underdahl LO, Smith HL. Coronary artery disease in women under the age of 40. Proc. Staff Meet. Mayo Clin. 1947; 22: 479.
6. Rivan AU, Dimitroff SP. The incidence and severity of atherosclerosis in estrogen-treated males, and in females with a hypoestrogenic or a hyperestrogenic state. Circulation 1954; 9: 533-9.
7. Oliver MF, Boyd GS. Effect of bilateral ovariectomy on coronary-artery disease and serum-lipid levels. Lancet 1959; 2: 690-4.
8. Robinson RW, Higano N, Cohen WD. Increased incidence of coronary heart disease in women castrated prior to the menopause. Arch. Intern. Med. 1959; 104: 908-13.
9. Wuest JH, Dry TJ, Edwards JE. The degree of coronary atherosclerosis in bilaterally oophorectomized women. Circulation 1953; 7: 801-8.
10. Ritterband AB, Jaffe IA, Densen PM, Magagna JF, Reed E. Gonadal function and the development of coronary heart disease. Circulation 1963; 27: 237-51.
11. Novack ER, William TJ. Autopsy comparison of cardiovascular changes in castrated and normal women. Am. J. Obstet. Gynecol. 1966; 80: 863-72.
12. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR. Menopause and risk factors for coronary heart disease. N. Engl. J. Med. 1989; 321: 641-6.
13. Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA. Postmenopausal use of estrogen and occlusion of coronary arteries. Am. Heart J. 1988; 115: 954-63.
14. Nabulsi AA, Folsom AR, White A et al. Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. N. Engl. J. Med. 1993; 328: 1069-75.
15. Fischer GM, Swain ML. Effect of sex hormone on blood pressure and vascular connective tissue in castrated and noncastrated male rats. Am. J. Physiol. 1977; 232: H617-21.
16. Wolinsky H. Effects of estrogen and progestogen treatment on the response of the aorta of male rates to hypertension. Morphological and chemical studies. Circ. Res. 1972; 30: 341-9.
17. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81: 1680-7.
18. Kushwaha RS, Lewis DS, Carey KD, McGill HC Jr. Effects of estrogen and progesterone on plasma lipoproteins and experimental atherosclerosis in the baboon (Papio sp.). Arterioscler. Thromb. 1991; 11: 23-31.
19. Knopp RH. Cardiovascular effects of endogenous and exogenous sex hormones over a woman's lifetime. Am. J. Obstet. Gynecol. 1988; 158: 1630-43.
20. Tikkanen MJ, Nikkilä EA, Kuusi T, Sipinen S. High density lipoprotein and hepatic lipase: Reciprocal changes produced by estrogen and norgestrel. J. Clin. Endocrinol. Metab. 1982; 54: 1113-17.
21. Tikkanen MJ, Kuusi T, Nikkilä EA, Stenman U-H. Variation of postheparin plasma hepatic lipase by menstrual cycle. Metabolism 1986; 35: 99-104.
22. Pick R, Stamler J, Rodbard S, Katz LN. The inhibition of coronary atherosclerosis by estrogen in cholesterol-fed chicks. Circulation 1952; 6: 276-80.
23. Stamler J, Pick R, Katz LN. Prevention of coronary atherosclerosis by estrogen-androgen administration in the cholesterol-fed chick. Circ. Res. 1953; 1: 94-8.
24. Adams MR, Kaplan JR, Koritnik DR, Clarkson TB. Pregnancy-associated inhibition of coronary artery atherosclerosis in monkeys: Evidence of a relationship with endogenous estrogen. Arteriosclerosis 1987; 7: 378-83.
25. Pick R, Stamler J, Rodbard S, Katz LN. Estrogen-induced regression of coronary atherosclerosis in cholesterol-fed chicks. Circulation 1952; 6: 858-61.
26. Barrett-Connor E, Wingard DL, Criqui MH. Postmenopausal estrogen use and heart disease risk factors in the 1980s. JAMA 1989; 261: 2095-2100.
27. Bush TL, Barrett-Connor E, Cowan LD. Cardiovascular mortality and non-contraceptive estrogen use in women: Results from the Lipid Research Clinics' Program Follow-up Study. Circulation 1987; 75: 1002-9.
28. Reynolds SRM, Foster FI. Peripheral vascular action of estrogen, observed in the ear of the rabbit. J. Pharmacol. Exp. Ther. 1940; 68: 173-84.
29. Silva de Sá MF, Meirelles RS. Vasodilation effect of estrogen on the human umbilical artery. Gynecol. Invest. 1977; 8: 307-13.
30. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. JACC 1993; 20: 452-7.
31. Maddox YT, Falcon JG, Ridinger M, Cunard CM, Ramwell PW. Endothelium-dependent gender differences in the response of the rat aorta. J. Pharmacol Exp. Ther. 1987; 240: 392-5.
32. Reis SE, Gloth ST, Blumenthal RS et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89: 52-60.
33. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90: 786-91.
34. Nichols NR, Olsson CA, Funder JW. Steroid effects on protein synthesis in cultured smooth muscle cells from rat aorta. Endocrinology 1983; 113: 1096-1101.
35. Horwitz KB, Horwitz LD. Canine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids. J. Clin. Invest. 1982; 69: 750-8.
36. Harder DR, Coulson PB. Estrogen receptors and effects of estrogen on membrane electrical properties of coronary vascular smooth muscle. J. Cell. Physiol. 1979; 100: 375-82.
37. Nakao J, Chang W-C, Murota S-I, Orimo H. Estradiol-binding sites in rat aortic smooth muscle cells in culture. Am. Heart J. 1981; 13767: 12336-13364.
38. Colburn P, Buonassisi V. Estrogen-binding sites in endothelial cell cultures. Science 1978; 201: 817-19.
39. Ricciardelli C, Honfall DJ, Skinner JM, Henderson DW, Marshall VR, Tilley WD. Development and characterization of primary cultures of smooth muscle cells from the fibromuscular stroma of the guinea pig prostate. In Vitro Cell. Dev. Biol. 1989; 25: 1016-24.
40. 2-like material in the rabbit. Prostaglandins 1980; 20: 1039-51.
41. Kakar SS, Sellers JC, Devor DC, Musgrove LC, Neill JD. Angiotensin II type-1 receptor subtype cDNAs: Differential tissue expression and hormonal regulation. Biochem. Biophys. Res. Commun. 1992; 183: 1090-6.
42. Green S. Promiscuous liaisons. Nature 1993; 361: 590-1.
43. Green S, Chambon P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet. 1988; 4: 309-14,
44. Luisi BF, Xu WX, Otwinowski Z, Freedman LP, Yamamoto KR, Sigler PB. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 1991; 352: 497-505.
45. Carlberg C, Bendik I, Wyss A et al. Two nuclear signalling pathways for vitamin D. Nature 1993; 361: 657-60.
46. Jensen EV, Desombre ER. Mechanism of action of the female sex hormones. Annu. Rev. Biochem. 1972; 41: 203-30.
47. King WJ, Greene GL. Monoclonal antibodies localize estrogen receptor in the nuclei of target cells. Nature 1984; 307: 745-7.
48. Welshons WV, Lieberman ME, Gorski J. Nuclear localization of unoccupied estrogen receptors. Nature 1984; 307: 747-9.
49. Spelsberg TC, Webster RA, Pikler GM. Chromosomal proteins regulate steroid binding to chromatin. Nature 1976; 262: 65-7.
50. Barrack ER, Coffey DS. The specific binding of estrogen and androgens to the nuclear matrix of sex hormone responsive tissues. J. Biol. Chem. 1980; 255: 7265-75.
51. Pardoll DM, Vogelstein B, Coffey DS. A fixed site of DNA replication in eucaryotic cells. Cell 1980; 19: 527-30.
52. Robinson SI, Nelkin BD, Vogelstein B. The ovalbumin gene is associated with the nuclear matrix of chicken oviduct cells. Cell 1985; 28: 99-106.
53. Walter P, Green S, Greene G et al. Cloning of the human estrogen receptor cDNA. Proc. Natl Acad Sci. USA 1985; 82: 7889-93.
54. Mendelsohn ME, Zhu Y, O'Neill S. The 29-kDa proteins phosphorylated in thrombin-activated human platelets are forms of the estrogen receptor-related 27-kDa heat shock protein. Proc. Natl Acad. Sci. USA 1991; 88: 11212-16 (Abstr.).
55. Picard D, Khursheed B, Garabedian MJ, Fortin MG, Lindquist S, Yamamoto KR. Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 1990; 348 (6297): 166-8.
56. Aitken SC, Lippman ME. Hormonal regulation of de novo pyrimidine synthesis and utilization in human breast cancer cells in tissue culture. Cancer Res. 1983; 43: 4681-90.
57. Aitken SC, Lippman ME. Effect of estrogens and antiestrogens on growth-regulatory enzymes in human breast cancer cells in tissue culture. Cancer Res. 1985; 45: 1611-20.
58. Dickson RB, Lippman ME. Control of human breast cancer by estrogen, growth factors, and oncogenes. In: Lippmann ME, Dickson RB (eds). Breast Cancer: Cellular and Molecular Biology. Kluwer Academic Publishers, Norwell MA. 1988; 119-65.
59. Cowan K, Levine R, Aitken S et al. Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate resistant human breast cancer cells. J. Biol. Chem. 1982; 257: 15079-86.
60. Kasid A, Davidson N, Gelmann E, Lippman ME. Transcriptional control of thymidine kinase gene expression by estrogens and antiestrogens in MCF-7 human breast cancer cells. J. Biol. Chem. 1986; 261: 5562-7.
61. Stack G, Gorski J. Direct mitogenic effect of estrogen on the prepuberal rat uterus: Studies on isolated nuclei. Endocrinology 1984; 115: 1141-50.
62. Sirbasku DA. Estrogen induction of growth factors specific for hormone-responsive mammary, pituitary, and kidney tumor cells. Proc. Natl Acad. Sci. USA 1978; 75: 3786-90.
63. Sporn MB, Todaro GJ. Autocrine secretion and malignant transformation of cells. N. Engl. J. Med. 1980; 303: 878-82.
64. Ma ZQ, Spreafico E, Pollio G et al. Activated estrogen receptor mediates growth arrest and differentiation of a neuroblastoma cell line. Proc. Natl Acad. Sci. USA 1993; 90: 3740-4.
65. Bradshaw MS, Tsai SY, Leng XH et al. Studies on the mechanism of functional cooperativity between progesterone and estrogen receptors. J. Biol. Chem. 1991; 266: 16684-90.
66. Jeng MH, Parker CJ, Jordan VC. Estrogenic potential of progestine in oral contraceptives to stimulate human breast cancer cell proliferation. Cancer Res. 1992; 52: 6539-46.
67. Coibion M, Kiss R, Jossa V et al. In vitro influence of estradiol or progesterone on the thymidine labeling indices of human benign breast tumors. Anticancer Res. 1989; 9: 475-82.
68. Scheven BA, Damen CA, Hamilton NJ, Verhaar HJ, Duursma SA. Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osleoblast-like cells in vitro. Biochem. Biophys. Res. Commun. 1992; 186: 54-60.
69. Caronti B, Palladini G, Bevilacqua MG et al. Effects of 17 beta-estradiol, progesterone and tamoxifen on in vitro proliferation of human pituitary adenomas: Correlation with specific cellular receptors. Tumour Biol. 1993; 14: 59-68.
70. Michna H, Nishino Y, Neef G, McGuire WL, Schneider MR. Progesterone antagonists: tumor-inhibiting potential and mechanism of action. J. Steroid Biochem. Mol. Biol. 1992; 41: 339-48.
71. Okulicz WC, Balsamo M, Tast J. Progesterone regulation of endometrial estrogen receptor and cell proliferation during the late proliferative and secretory phase in artificial menstrual cycles in the rhesus monkey. Biol. Reprod. 1993; 49: 24-32.
72. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994; 89: 1501-10.
73. Pickering JG, Weir J, Rosenfield K, Stetz J, Jekanowski J, Isner JM. Smooth muscle cell outgrowth from human atherosclerotic plaque: Implications for the assessment of lesion biology. J. Am. Coll. Cardiol. 1992; 20: 1430-9.
74. Horwitz KB, Costlow ME, McGuire WL. MCF-7: A human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors. Steroids 1975; 26: 785-95.
75. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994; 89: 1943-50.
76. Klein-Hitpass L, Kaling M, Ryffel GU. Synergism of closely adjacent estrogen-responsive elements increases their regulatory potential. J. Mol. Biol. 1988; 201: 537-44.
77. Klein-Hitpass L, Ryffel GU, Heitlinger E, Cato AC. A 13bp palidrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucleic Acids Res. 1988; 16: 647-63.
78. Kumar V, Chambon P. The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer. Cell 1988; 55: 145-56.
79. Hiort O, Kwan PWL, DeLellis RA. Immunohistochemistry of estrogen receptor protein in paraffin sections: Effects of enzymatic pretreatment and cobalt chloride intensification. Am. J. Clin. Pathol. 1988; 90: 559-63.
80. Rutqvist LE, Mattsson A. Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. J. Natl Cancer Inst. 1993; 85: 1398-1406.
81. Liang P, Pardee AB. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 1992; 257: 967-71.
82. Liang P, Averboukh L, Pardee AB. Distribution and cloning of eukaryotic mRNA's by means of differential display: Refinements and optimization. Nucleic Acids Res. 1993; 21: 3269-75.